Clinical Trials Logo
  1. Home
  2. Lymphoma, T-Cell, Peripheral
  3. NCT02788916

A Retrospective Study of Clinical, Phenotypic and Genetic Factors of Peripheral T-Cell Lymphomas

Lymphoma, T-Cell, Peripheral Clinical Trial

Official title:
A Retrospective Study of Clinical, Phenotypic and Genetic Factors of Peripheral T-Cell Lymphomas in the Spanish Population

Clinical Trial Summary

The purpose of this study is to establish the distribution of peripheral T-cell lymphocyte (PTCL) subtypes by re-analysis and re-classification of samples according to the 2008 World Health Organization (WHO) classification of lymphoid neoplasms.

Clinical Trial Description

This study is a retrospective, non-interventional and, post-authorization observational study of other designs (PAS-OD).

This multicenter trial will be conducted in Spain. Retrospective review of medical records and initial tumor biopsies of participants diagnosed with PTCL in the period of 6 years between 01/01/2008 and 31/12/2013 will be performed. Initial tumor biopsies and histological preparations, filed and previously anonymized, will be sent to the central laboratory for assessment. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02788916
Study type Observational
Source Takeda
Contact
Status Completed
Phase N/A
Start date September 25, 2015
Completion date January 12, 2017
View Details
See also
  Status Clinical Trial Phase
Active, not recruiting NCT03547700 - Study of Ixazomib and Romidepsin in Peripheral T-cell Lymphoma (PTCL) Phase 1/Phase 2
Completed NCT02567656 - Safety and Efficacy Study of a Dual PI3K Delta/Gamma Inhibitor in T-cell Lymphoma Phase 1
Completed NCT01142674 - T-Cell Project: Prospective Collection of Data in Patients With Peripheral T-Cell Lymphoma
Withdrawn NCT03355768 - Romidepsin Versus Combination of Romidepsin Plus Pralatrexate in PTCL Phase 3
Not yet recruiting NCT05006664 - Brentuximab Vedotin in Combination With CHEP in Patient With PTCL Phase 2
Terminated NCT00514722 - Pilot Study of Umbilical Cord Blood Transplantation in Adult Patient With Advanced Hematopoietic Malignancies N/A
Completed NCT01679860 - Intensive Chemo-immunotherapy as First Line Treatment in Adult Patients With Peripheral T- Cell Lymphoma Phase 2
Recruiting NCT06254495 - A Safety Study of SGN-35C in Adults With Advanced Cancers Phase 1
Completed NCT05137847 - A Study of Remitoro in Participants With Recurrent or Refractory Peripheral T Cell Lymphoma and Cutaneous T Cell Lymphoma (All Case Study)
Terminated NCT03601819 - Pacritinib in Relapsed/Refractory Lymphoproliferative Disorders Phase 1
Completed NCT03049449 - T Cells Expressing a Fully-Human Anti-CD30 Chimeric Antigen Receptor for Treating CD30-Expressing Lymphomas Phase 1
Completed NCT00211185 - A Study of ONTAK and CHOP in Newly Diagnosed, Peripheral T-Cell Lymphoma Phase 2
Not yet recruiting NCT03051568 - Evaluating 18F-FDG PET/CT With Liver SUVmax-based Criteria for Prognosis of Patients With Peripheral T-cell Lymphoma N/A
Not yet recruiting NCT03051581 - 18F-FDG PET/CT-based Prognostic Model for Predicting Outcome in Patients With Peripheral T-cell Lymphoma N/A
Completed NCT00646854 - Alemtuzumab and CHOP in T-cell Lymphoma Phase 3
Terminated NCT02535247 - Study of MK-3475 Alone or in Combination With Copanlisib in Relapsed or Refractory NK and T-cell Non-Hodgkin Lymphoma Phase 1/Phase 2
Recruiting NCT02364466 - Cohort of Peripheral T Cell Lymphoma N/A
Recruiting NCT02404571 - GDP in Frontline Chemotherapy for Patients With PTCL-NOS Phase 2
Completed NCT03742921 - ISTODAX® for Intravenous Infusion Drug Use Results Survey- Relapsed or Refractory Peripheral T-Cell Lymphoma
Completed NCT02181218 - Phase I Study of Romidepsin, Gemcitabine, Oxaliplatin, and Dexamethasone in Patients With Relapsed/Refractory Aggressive Lymphomas Phase 1